Skip to main content
Equibles
IMA logo

IMA · ImageneBio, Inc.

Track IMA — free

Use IMA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IMA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.21 -0.05 (-1.17%)
Rebalance outlook locked
Market Cap
$48.36M
Shares
11.35M
Volume · Oct 9 2156 Avg daily vol (3M) 13.09K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.26 Open$4.48 Day$4.00–4.48 52W close$4.26–8.79 Avg vol 30d16K Short int35K · 0.3% float · 2.3d Short vol21% Last earningsMay 15, 2026 DataMar 2021–Oct 2026 Filing10-Q · Aug 5

Up next

Latest filing: 10-Q
filed Aug 5, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$52.48M
Trailing 12 months
Revenue growth YoY
-100.0%
Year over year
Operating margin
-6,056.4%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+571.6%
Year over year · more shares
Price change (1Y)
-44.7%
Trailing year
Short interest
0.3%
Latest settlement · 2.3 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 15.4 · calm Equity put/call 0.62
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −27%
below
Price vs 50-day avg −18%
below
RSI (14) 26
oversold
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −15%
trailing
6-month return −28%
trailing
YTD return −38%
this year
Relative strength −37%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $5 › 200d $6 — 200d above 50d
Institutional flow Distributing
-10% holders QoQ · +4 funds added
Insider flow Distributing
Net -$17.3K over 90 days · 100% sells
Short interest Falling
0.30% of float · ▼ -12.2% MoM · 2.3 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
35 holders — mid 3-yr range
Squeeze score 37
low risk · 0–100
Fundamentals
Weak
Revenue growth −77%
Y/Y
EPS growth +56%
Y/Y
Free cash flow $-48.3M
Quant / Vol
risk profile
Very High
Volatility 58%
annualized · 1-yr
Max drawdown −52%
past year
ATR 5.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−27% Bearish
Price vs 50-day avg
−18% Bearish
RSI (14)
26 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $5 › 200d $6 — 200d above 50d
Institutional flow Distributing
-10% holders QoQ · +4 funds added
Insider flow Distributing
Net -$17.3K over 90 days · 100% sells
Short interest Falling
0.30% of float · ▼ -12.2% MoM · 2.3 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
35 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $4 Now $4 · 0% Range high $9
vs 200-day avg -27% vs 50-day avg -18%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
IMA
ImageneBio, Inc.
this stock
$48.36M -38.3% -77.1% — 0.3%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $127.55B +11.0% +46.2% 29.3 1.9%
MRNA
Moderna, Inc.
 $78.65B +568.0% +4.3% — 8.2%
REGN
Regeneron Pharmaceuticals, Inc.
 $76.14B -4.2% +20.8% 18.3 2.5%
CSLLY
Csl Ltd
 $60.24B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
35
% held
54.9%
Net QoQ
+878.7K sh
Top holder
BVF INC/IL
Held Float
View
Held by Funds
Fund positions
11
View
Short & Settlement
Short Interest Falling
Shares short
34.6K
Days to cover
2.3d
Change
-4.8K sh
View
Short Volume
Short vol %
21%
As of
Oct 8, 2026
Short Total
View
Fails to Deliver
FTD shares
1
Value
$5
As of
Sep 11, 2026
View
Off-Exchange
Off-exchange %
48.5%
Week of
Aug 31, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$17.3K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$800.0K
Net income (FY)
$-45.3M
EPS diluted
$-9.64
View
Filings
SEC Filings
Latest
Investor Event Transcript
Filed
Sep 14, 2026
This year
15
View
Exempt Offerings
Offering
$75.0M
Filed
Jul 18, 2025
View
Earnings & Events
Webcasts
Last webcast
Sep 14, 2026
View

Performance

5D 20D 120D MTD YTD
IMA -7.0% -14.9% -27.8% -7.0% -38.3%
SPY +1.3% +2.1% +9.0% +1.5% +13.5%
vs SPY -8.3% -17.0% -36.8% -8.5% -51.8%
Key facts CIK 1835579 CUSIP 45175G207 Visit website Investor relations